Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. uri icon

authors

  • Shannon R. McCurdy, MD
  • Brodsky, Robert A
  • Gladstone, Douglas E
  • Huff, Carol Ann
  • Pratz, Keith W
  • Prince, Gabrielle T
  • Dezern, Amy E
  • Gojo, Ivana
  • Matsui, William H
  • Borrello, Ivan
  • McDevitt, Michael A
  • Kanakry, Jennifer A
  • Swinnen, Lode J
  • Smith, B Douglas
  • Levis, Mark J
  • Ambinder, Richard F
  • Luznik, Leo
  • Jones, Richard J
  • Fuchs, Ephraim J
  • Kasamon, Yvette L
  • Showel, Margaret M
  • Tsai, Hua-Ling
  • Bolaños-Meade, Javier
  • Rosner, Gary L
  • Kanakry, Christopher G
  • Perica, Karlo
  • Symons, Heather J

publication date

  • March 26, 2015

published in